This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (14)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • World Health  • Pulmonary Diseases, Other  • Tuberculosis/ Other Mycobacterium  • Screening  • Alert me on articles by topic

Measure for Measure

Christopher C. Whalen, MD, MS

JAMA. 2005;293:2785-2787.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 2003, the World Health Organization reported 8.8 million cases of tuberculosis (TB) worldwide, nearly half of them presenting with an infectious form of disease, and resulting in 1.7 million deaths from TB. Since TB transmission occurs before diagnosis in the index case, even when an optimal TB control program is in place,¹ new and undiagnosed cases are the driving force behind the current TB epidemic. If each new TB case in 2003 infected up to 10 susceptible contacts² before diagnosis, up to 40 million new infections could have occurred worldwide that year alone. Since TB has a long period of latent infection, these new infections added to the pool of existing infections, which represents a source for potential TB cases in the years, and even decades, to come. One strategy for global TB control would be to implement an effective screening program in high-risk . . . [Full Text of this Article]

TB Control

Author Affiliation: Department of Epidemiology and Biostatistics and the Tuberculosis Research Unit, Case Western Reserve University School of Medicine, Cleveland, Ohio.

RELATED ARTICLES

Mycobacterium tuberculosis Infection in Health Care Workers in Rural India: Comparison of a Whole-Blood Interferon Assay With Tuberculin Skin Testing
Madhukar Pai, Kaustubh Gokhale, Rajnish Joshi, Sandeep Dogra, Shriprakash Kalantri, Deepak K. Mendiratta, Pratibha Narang, Charles L. Daley, Reuben M. Granich, Gerald H. Mazurek, Arthur L. Reingold, Lee W. Riley, and John M. Colford, Jr
JAMA. 2005;293(22):2746-2755.
ABSTRACT | FULL TEXT  

Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country
Young Ae Kang, Hye Won Lee, Ho Il Yoon, BeLong Cho, Sung Koo Han, Young-Soo Shim, and Jae-Joon Yim
JAMA. 2005;293(22):2756-2761.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Potential effect of NICE tuberculosis guidelines on paediatric tuberculosis screening
Taylor et al.
Arch. Dis. Child. 2008;93:200-203.
ABSTRACT | FULL TEXT  

Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.
Tsiouris et al.
J. Clin. Microbiol. 2006;44:2844-2850.
ABSTRACT | FULL TEXT  

Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Diel et al.
Eur Respir J 2006;28:16-23.
ABSTRACT | FULL TEXT  

IMMUNE CORRELATES OF ACUTE MYCOBACTERIUM TUBERCULOSIS INFECTION IN HOUSEHOLD CONTACTS IN KAMPALA, UGANDA.
WHALEN et al.
Am J Trop Med Hyg 2006;75:55-61.
ABSTRACT | FULL TEXT  

Advances in the diagnosis and treatment of tuberculosis.
Nahid et al.
Proc Am Thorac Soc 2006;3:103-110.
ABSTRACT | FULL TEXT  

Tuberculosis--A Global Problem Requiring a Global Solution
DeAngelis and Flanagin
JAMA 2005;293:2793-2794.
FULL TEXT